Выпуск №2 за 2012 год - articles list

Выпуск №2 за 2012 год
XXI century without exaggeration to be called the century of information. During the last three years there has been a technological breakthrough, manifested by advent of new equipment and...
Выпуск №2 за 2012 год
The approach to the pathogenesis, diagnosis and treatment of diseases of the pelvic organs has changed, becoming more complex. It is connected with the phenomenon of so-called cross-sensitization,...
Выпуск №2 за 2012 год
Objective: to improve the efficacy of treatment of acute lower urinary tract infection (LUTI) and increase of recurrent-free period in chronic infection of lower urinary tract by a rational...
Выпуск №2 за 2012 год
In this literature review we examine the current data on the physiological roles and mechanisms of spontaneous rhythmic contractile activity of the urinary system and prostate. The data shows that in...
Выпуск №2 за 2012 год
Aims. To compare a modified insideout transobturator procedure, using a shortened sling and reduced dissection, with its original counterpart (TVT-O™) for the treatment of female stress urinary...
Выпуск №2 за 2012 год
Introduction: The most common techniques for hypospadias surgical treatment in patients with distal and penile hypospadias (primary and secondary surgeries) are: tubularized incised plate (TIP)...
Выпуск №2 за 2012 год
Introduction. In recent years the indications for organ preserving surgery in patients with kidney cancer have expanded. The main criteria of organ sparing surgery are local recurrence rate and long-...
Выпуск №2 за 2012 год
Chemoprevention is the effect aimed at postponing the development of cancer or extension of time to progression. This can be achieved through the use of means slowing down the progression, causing...
Выпуск №2 за 2012 год
Focal treatment of prostate cancer is possible only in case of precise localization of tumor inside prostate gland. Risk stratification and tumor mapping are the necessary conditions for the...
Выпуск №2 за 2012 год
Currently a huge experience of using phosphodiesterase type 5 inhibitors as a standard first line therapy of erectile dysfunction was accumulated. Meanwhile high price and significant risk of...

Readera - Социальная платформа публикаций

Crossref makes research outputs easy to find, cite, link, and assess